|
KMID : 1141720210090010006
|
|
폐쇄성폐질환
2021 Volume.9 No. 1 p.6 ~ p.10
|
|
|
|
|
Ra Seung-Won
|
|
|
Abstract
|
|
|
|
The global outbreak of COVID-19 has brought into focus the need for clear guidance on the use of aerosol-generating procedures, such as nebulization, for the treatment of patients with respiratory diseases with or without COVID-19. Despite a scarcity of evidence, there is heightened concern about the potential risk of transmission of SARS-CoV-2 in the form of aerosolized respiratory droplets during the nebulized treatment of patients with COVID-19. In this review, we describe the risk of transmission by nebulizer use in the era of COVID-19 pandemic.
|
|
|
KEYWORD
|
|
|
COVID-19, Nebulizer, Aerosol
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|